Global News

The Pulse on Global Trials

Monday, June 30, 2014 07:00 AM

At this month’s DIA annual meeting in San Diego, I gave a talk on leveraging the digital ecosystem for patient recruitment.

More... »

WIRB Copernicus Group

Aurinia Pharmaceuticals initiates phase IIb trial of Voclosporin for lupus nephritis

Friday, June 27, 2014 01:19 PM

Aurinia Pharmaceuticals has enrolled the first patient in its planned phase IIb clinical trial to evaluate the efficacy of voclosporin as a treatment for lupus nephritis (LN). LN is an inflammation of the kidneys, that if inadequately treated can lead to end-stage renal disease, making LN a serious and potentially life-threatening condition. The Lupus Foundation of America believes there are as many as 1.5 million people in the U.S. with systemic lupus erythematosus (SLE), approximately 40% to 70% of whom will develop LN.

More... »

CRF Health eCOA webinar series

Jennifer Doudna, Emmanuelle Charpentier win award for biomedical research

Friday, June 27, 2014 12:53 PM

Johnson & Johnson has named Dr. Jennifer Doudna of the University of California at Berkeley and the Howard Hughes Medical Institute, and Dr. Emmanuelle Charpentier, of the Hannover Medical School and Helmholtz Center for Infection Research (HZI), Germany and the Laboratory for Molecular Infection Medicine Sweden (MIMS), Umea University, Sweden, the winners of the 2014 Dr. Paul Janssen Award for Biomedical Research. Their collaboration led to the discovery of a new method for precisely manipulating genetic information in ways that should produce new insights in health and disease, and may lead to the discovery of new targets for drug development.

More... »

Liomont, Oncobiologics partner to launch biosimilars in Mexico

Friday, June 27, 2014 11:13 AM

Oncobiologics, a privately held biopharmaceutical company, and Laboratorios Liomont, a Mexico City-based pharmaceutical company, have partnered for the development, manufacture and commercialization of biosimilar monoclonal antibody products for the Mexican market. The agreement includes exclusive commercialization in Mexico by Liomont of two biosimilars developed by Oncobiologics.

More... »

Alzheimer's Drug Discovery Foundation, OnDeckBiotech partner

Friday, June 27, 2014 11:12 AM

The Alzheimer's Drug Discovery Foundation (ADDF) and OnDeckBiotech, a Boston-based software company providing software tools for biotech, pharma and R&D service vendors, are partnering to provide a new platform technology for ADDF ACCESS, an open-access database that provides a network of CROs, drug development consultants and educational resources focused for diseases of the central nervous system (CNS).

More... »

Corgenix, VHFC receive $2.9M NIH grant to develop Ebola rapid diagnostic test kit

Friday, June 27, 2014 11:10 AM

Corgenix Medical, a worldwide developer and marketer of diagnostic test kits, has been awarded a three-year, $2.9 million NIH grant to advance the development of an Ebola rapid diagnostic test kit. Collaborating with Corgenix on the program will be members of the Viral Hemorrhagic Fever Consortium (VHFC), a collaboration of academic and industry members headed by Tulane University and partially funded by the NIH.

More... »

Merz to acquire medical device company Ulthera

Friday, June 27, 2014 11:09 AM

Specialty healthcare company Merz will acquire Ulthera, a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications using its ultrasound platform technology. The merger is valued at up to $600 million in upfront cash and milestone payments.

More... »

HedgePath Pharmaceuticals adds three new board members

Thursday, June 26, 2014 03:36 PM

HedgePath Pharmaceuticals, a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, has announced that Stefan J. Cross, Dr. R. Dana Ono and W. Mark Watson, CPA, have been appointed to HedgePath's board of directors.

More... »

FDA approves Sivextro to treat skin infections

Thursday, June 26, 2014 03:02 PM

The FDA has approved Sivextro (tedizolid phosphate), a new antibacterial drug, to treat adults with skin infections.

More... »

Battelle, BIO find bioscience industry has strong growth prospects

Thursday, June 26, 2014 02:18 PM

A study by Battelle and BIO analyzing the U.S. bioscience industry growth over the last 11 years—through recession and early economic recovery—reveals positive trends. The industry demonstrated a strong record of growth from 2001 to 2012, has navigated the deep economic recession better than most industries and is once again growing.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 21

As job growth in drug development sector soars, more employees are seeking new opportunities

U.K. study: Prisoners should have the right to participatein clinical trials on moral grounds, for healthcare access

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs